T-Cell Immunotherapy Market

30 Apr

T-Cell Immunotherapy Market Poised to Grow at a Healthy CAGR by 2024:

  • By admin

  • January, 1970

Infinium Global Research has added a new report on T-Cell Immunotherapy Market. The report presents an analysis of global as well as regional markets of t-cell immunotherapy market over the period of 2016 to 2024. The growing occurrence of cancer in both children as well as in adults creates a huge demand for effective treatments.  The rising incidence of cancer across the globe is a key factor driving the growth of T cell immunotherapy market. Reliable and effective treatments offered by the T cell with the minimum side effects as compared to the other traditional therapies are contributing in the growth of T cell immunotherapy market. In addition, on-going development to improve the existing therapies and rising innovations to provide more effective therapy options are anticipated to boost the growth of T cell immunotherapy market. However, the neurological problems associated with the T cell immunotherapy is expected to be the restraining factor in the T cell immunotherapy market. Moreover, various health organisations and government agencies are taking the initiative to find effective therapy to treat cancer. The rapidly increasing research and development activities and technological advancement in the cancer treatment are projected to create several opportunities for the T cell immunotherapy market in upcoming years.  Furthermore, The Food and Drug Administration (FDA) has approved CAR T-cell therapy, axicabtagene ciloleucel (Yescarta), for the treatment of diffuse large B-cell lymphoma (DLBCL) and CAR T-cell therapy tisagenlecleucel (Kymriah) to treat cancer in the Childers and adults.

 

Geographically, North America held the maximum market share in the T cell Immunotherapy market owing to the rising occurrence of cancer. The developed healthcare infrastructure of North America contributes to the growth of T cell Immunotherapy market. In addition, Asia Pacific is the fastest growing region in the T cell Immunotherapy. The developing healthcare infrastructure, growing geriatric population and rising occurrence of cancer are the primary factors driving the growth of T cell Immunotherapy market in the Asia Pacific region Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global t-cell immunotherapy market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for the forecast period of 2018-2024.

 

Get 15% discount for early purchase of global t-cell immunotherapy market report by clicking the following link, Use code IGRD15 to request the discount in the given form

 

https://www.infiniumglobalresearch.com/reports/request-discount/1844

 

The recent report identified that North America dominated the global t-cell immunotherapy market over the last couple of years while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the t-cell immunotherapy market worldwide.

 

The report segments the global T-cell immunotherapy market on the basis of Mechanism of Action, Type of therapy and Product Class.

 

Global T-cell Immunotherapy Market by Mechanism Of Action

·         Active Immunotherapy

·         Passive Immunotherapy

 

Global T-cell Immunotherapy Market by Type Of Therapy

·         CAR-T

·         TCR

·         TIL

 

Global T-cell Immunotherapy Market by Product Class

·         Monoclonal Antibodies

·         Oncolytic Virus Therapy

·         Bispecific Antibodies

·         Cytokines

 

Companies Profiled in the Report

·         Adaptimmune Therapeutics

·         bluebird bio

·         innovative Cellular Therapeutics

·         Novartis

·         Sinobioway Cell Therapy

·         Cellectis

·         CARsgen Therapeutics

·         Autolus

·         Celgene

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.